Agenus shared a post on LinkedIn:
“Breelyn Wilky, sat down with the Journal of Clinical Oncology to discuss the recent publication on the Phase 1 study results of botensilimab/balstilimab, highlighting its potential in treating advanced sarcomas.
Listen to the full discussion.”